BioCentury
ARTICLE | Clinical News

Simbrinza brinzolamide/brimonidine tartrate regulatory update

August 11, 2014 7:00 AM UTC

Novartis’ Alcon Inc. ophthalmic unit said the European Commission approved an MAA for Simbrinza brinzolamide/brimonidine tartrate to reduce intraocular pressure (IOP) in adults with open-angle glauco...